Clinical trial
A Double-blind Randomized Controlled Trial of 1% Lidocaine Paracervical Block for Endometrial Biopsy
NCT06546254 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Randomized Controlled Trial of 1% Lidocaine Paracervical Block for Endometrial Biopsy
- Lead sponsor
- Mount Sinai Hospital, Canada
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 19, 2025
- Completion date
- January 22, 2026
- Enrollment
- 96 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial biopsy